Lincomycin Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lincomycin Hydrochloride Injection (injection) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 02/25/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Pfizer Inc.
- Package NDC
- 0009-0104-04
- Dosage Form
- Injection
- Presentation
- Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04)
- Initial Posting
- 02/25/2026
- Revised Date